Valuation check: TELIF's profit margin is 50.3%, above the Healthcare sector average of 9.71%.
Get informed when a big investor buys or sells
+ FollowAs of Aug 2026
Trailing 12 months ending Aug 2026
The latest profit margin for TELIF is 50.3% as of August 2026. That compares with -17.32% in the prior-year period — up 390.4% year over year. That is above the Healthcare sector average of 9.71%. Investors often review this figure alongside Telescope Innovations's historical trend and sector peers before judging valuation or financial health.
Over the past year, TELIF's profit margin moved from -17.32% to 50.3% — a 390.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Telescope Innovations's valuation or profitability profile.
Against Healthcare companies, TELIF currently prints 50.3% for profit margin, while the sector average sits near 9.71%. That is roughly 418.3% above the sector mean. Large gaps often invite a closer look at Telescope Innovations's growth, margins, and balance sheet.
Profit Margin shows how effectively Telescope Innovations converts resources into returns. At 50.3%, TELIF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -17.32% in the prior-year period — up 390.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting TELIF's profit margin (50.3%), review year-over-year change from -17.32%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.